Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
64 Total results for product and free and sample content found
In Vivo
08 Oct 2021
The highly anticipated Outlook 2022 report from Pharma Intelligence is coming soon. Reach the thousands of senior decision makers who eagerly await this pharma industry ranking and review for the year ahead, with sponsorship opportunities that align your brand with our trusted information.
Pharma Intelligence Apps
01 Jul 2021
Held in Milan to Recognize Excellence in Pharma
Topic Innovation BioPharmaceutical
01 Apr 2021
Learn about the latest trends affecting biopharma R&D including, study diversity & transparency, predictive feasibility and more...
Scrip
25 Feb 2021
For Scrip’s annual preview our journalists asked over 200 industry executives and experts for their predictions of the major trends for 2021. From the pandemic, to AI, therapeutics, and the new US leadership, here’s what to watch out for – in a year with so much at stake.
Scrip
By Ian Haydock 22 Feb 2021
A resolution in a long-running patent dispute, expansion of coronavirus vaccine production, drug development trends over the past decade, hematological malignancies in a clinical trial, and the last instalment in the Scrip Asks series all feature in this week's podcast version of Scrip's Five Must-Know Things.
Topic BioPharmaceutical
Generics Bulletin
By Penelope MacRae 27 Nov 2020
The US FDA has slapped Biocon with a dozen observations over three units at its insulin manufacturing facility in Malaysia, but the Indian biotech firm says the problems can be remedied quickly and that US launch plans are on track for its insulin product glargine challenging French drug-maker Sanofi’s multi-billion-dollar Lantus.
Topic FDA Diabetes BioPharmaceutical
Scrip
By Jessica Merrill 27 Nov 2020
Industry advisers at the BIO CEO & Investor meeting remained optimistic about the pharmaceutical deal environment in 2020 – even with the uncertainty around a looming US election year.
Topic BioPharmaceutical
Trialtrove
27 Nov 2020
See last year’s clinical trial activity through the eyes of our expert analysts and get a better sense of where the industry is headed. This new whitepaper is the annual analysis of Phase I-III clinical trials, from Citeline’s Trialtrove, and reveals the priorities and strategies of the biopharma industry.
Topic Drug Development Landscape BioPharmaceutical Business Strategies
Scrip
By Andrew McConaghie 17 Nov 2020
The companies look to have secured a better than expected 90% efficacy level, but will await safety data before filing later this month.
Topic Coronavirus BioPharmaceutical
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
